Treatment options in juvenile myoclonic epilepsy (Q45383090)

14 December 2017

title

Treatment options in juvenile myoclonic epilepsy (English)

1 reference

14 December 2017

2

1 reference

14 December 2017

Laura Mantoan

1

1 reference

14 December 2017

publication date

1 August 2011

1 reference

Current treatment options in neurology

14 December 2017

published in

1 reference

14 December 2017

volume

13

1 reference

14 December 2017

issue

4

1 reference

14 December 2017

page(s)

355-370

1 reference

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

The importance of drug interactions in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Polycystic ovary syndrome in women using valproate: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

The fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Effects of in utero antiepileptic drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Age and Comedications Influence Levetiracetam Pharmacokinetics in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Oral contraceptives reduce lamotrigine plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Preliminary results on pregnancy outcomes in women using lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Topiramate in patients with juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Clonazepam in juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Intermittent clobazam for catamenial epilepsy: tolerance avoided

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Clonazepam use in pregnancy and the risk of malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Double-Blind, Placebo-Controlled, Lamotrigine in Treatment-Resistant Generalised Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11940-011-0131-Z

Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy

21 January 2018

1 reference

12 December 2020

Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate

1 reference

12 December 2020

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

12 December 2020

Treatment of pediatric epilepsy: European expert opinion, 2007.

1 reference

12 December 2020

Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy

1 reference

12 December 2020

The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.

1 reference

12 December 2020

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

1 reference

12 December 2020

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

1 reference

12 December 2020

Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics

1 reference

12 December 2020

10.1007/S11940-011-0131-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

1050915490

0 references

1 reference